Outcomes Fund

Phaidra, Inc. is an AI solutions provider based in Seattle, Washington, founded in 2019. The company specializes in developing artificial intelligence-powered control systems tailored for large industrial facilities. Phaidra's technology analyzes vast amounts of sensor data to create intelligent agents that optimize complex operations. This virtual plant operator enhances the performance of mission-critical facilities by improving energy efficiency, stability, and sustainability. Through its closed-loop AI control service, Phaidra enables operations teams to achieve significant operational improvements, thereby maximizing yield and enhancing safety within industrial environments.

Lark is a developer of a virtual chronic disease prevention and management platform that offers personalized support and counseling to users. Utilizing advanced artificial intelligence alongside human coaches and connected devices, Lark provides real-time, 24/7 assistance, helping individuals make healthier choices and manage chronic conditions effectively. The company has established CDC-recognized programs, including its Diabetes Prevention Program, Wellness Program, Diabetes Care Program, and Hypertension Program, which collectively serve 1.5 million users. These initiatives have shown clinically validated improvements in health outcomes, as documented in 11 peer-reviewed journals and analyst reports. Founded in 2011 by Julia Hu and Jeff Zira, Lark is headquartered in Mountain View, California.

nFlux AI is focused on developing an artificial general intelligence platform that aims to enhance human capabilities through advanced cognitive technologies. The company initially collaborated with NASA to create a cognitive architecture capable of supporting deep space missions, where communication with Earth is limited. This intelligent system is designed to assist astronauts autonomously, independent of ground control. In addition to its work with NASA, nFlux AI specializes in computer vision operations, offering intelligent video analytics that automate the extraction of contextual insights from unstructured video data. This capability allows clients to gain a deeper understanding of their data through proprietary machine comprehension services. The company's growth has been supported by investments from notable entities, including the Amazon/Alexa Fund and Techstars, enabling nFlux AI to expand its platform and team to further its mission.

ECFX, Inc. is a software development company based in Venice, California, that focuses on providing solutions for the legal industry. Established in 2019, ECFX offers ECFX Notice, an enterprise notice management system designed to automate the workflow associated with electronic court notices. This innovative software streamlines processes by automatically downloading, profiling, storing, and distributing court documents from both Federal and State courts. It enhances efficiency by eliminating repetitive manual tasks and allows law firms to define their own policies for document handling. Users can receive court documents in various formats and benefit from email notifications that include essential internal data. Additionally, the platform features a powerful Analytics Dashboard that enables administrators to monitor electronic court filing activities, thereby saving time and reducing risks linked to manual data entry.

Neyborly is a commercial real estate company focused on transforming under-utilized urban spaces into vibrant venues for events, meetings, and pop-up activities. By revitalizing vacant properties, Neyborly creates unique and customizable gathering spaces that cater to a variety of occasions, from birthday parties to art shows. The company aims to democratize access to attractive and affordable real estate in local neighborhoods, fostering community engagement and collaboration. Through its innovative approach, which combines design, data, and exceptional customer service, Neyborly seeks to redefine the traditional real estate landscape and inspire individuals to celebrate and connect within their communities.

Activeconnect works on all types of devices and operating systems for every transaction including iOS, Android, Windows, and Mac OS. We provide a well-documented API and everything needed to build applications that have frictionless step-up authentication without needing passwords. Activeconnect’s technology powers authentication for any platform, web application, mobile application, software, and just about everything that needs user authentication and secure transactions. We help our Clients Avoid Account Takeover (ATO), reduce fraud and enable frictionless security steps to make any transaction secure, easy, cost-effective, and instantly scalable.

Athira Pharma, Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington, focused on developing small molecules aimed at restoring neuronal health and addressing neurodegenerative diseases. The company's lead candidate, ATH-1017, is a small hepatocyte growth factor/MET activator designed to penetrate the blood-brain barrier and is currently undergoing various clinical trials for the treatment of Alzheimer's and Parkinson's diseases. Additionally, Athira is advancing other candidates, including ATH-1019, which is in preclinical development for depression, and ATH-1018, aimed at treating peripheral neuropathy. Founded in 2011 and originally named M3 Biotechnology, Athira Pharma changed its name in April 2019 to reflect its commitment to innovative therapies that positively impact individuals affected by brain disorders.